FdaApplication

ANDA 217460

Back to search

Identifiers

Properties

PropertyValue
applicant_nameAMNEAL PHARMACEUTICALS LLC
application_typeANDA
approval_date2023-06-14

Products (1)

ProductActive ingredientStrengthDosage form
MOMETASONE FUROATEMOMETASONE FUROATE0.05MG/SPRAYSPRAY, METERED;NASAL

1 product